WallStreetZenWallStreetZen

NASDAQ: RPRX
Royalty Pharma PLC Stock Ownership - Who owns Royalty Pharma?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Royalty Pharma PLC insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Pablo G. LegorretaCEO Chairman of the Board2023-05-24150,000$32.25
$4.84MBuy
Rory B. RiggsDirector2023-05-221,750,000$32.82
$57.44MSell
Pablo G. LegorretaCEO Chairman of the Board2023-05-1769,612$32.94
$2.29MBuy
Pablo G. LegorretaCEO Chairman of the Board2023-05-16160,388$33.57
$5.38MBuy
Bonnie L. BasslerDirector2023-03-311,049$35.73
$37.48kBuy
Henry A. FernandezDirector2023-03-311,049$35.73
$37.48kBuy
Rory B. RiggsDirector2023-03-30130,024$36.26
$4.71MSell
Rory B. RiggsDirector2023-03-299,926$36.95
$366.77kSell
George W. LloydEVP Investments CLO2023-03-2912,779$37.03
$473.17kSell
George W. LloydEVP Investments CLO2023-03-28100,000$37.06
$3.71MSell

1 of 7

RPRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RPRX insiders and whales buy or sell their stock.

RPRX Shareholders

What type of owners hold Royalty Pharma PLC stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Morgan Stanley7.80%47,350,458$1.53BInstitution
Fmr LLC6.59%39,984,116$1.29BInstitution
Adage Capital Partners GP LLC6.38%38,714,280$1.25BInsider
Vanguard Group Inc6.25%37,930,019$1.22BInstitution
1978 Sicaf Sif Sa 1. Gg3.64%22,081,156$711.90MInsider
1978 Sicaf Sif Sa Gg3.53%21,426,170$690.78MInsider
Blackrock Inc3.27%19,848,842$639.93MInstitution
Baillie Gifford Co3.12%18,918,750$609.94MInstitution
Viking Global Investors LP1.85%11,204,249$361.22MInstitution
Jpmorgan Chase Co1.43%8,671,563$279.57MInstitution

1 of 3

RPRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RPRX48.10%16.18%Net SellingNet Selling
ARGX56.18%0.00%
BMRN93.18%1.51%Net SellingNet Selling
ALNY81.04%18.96%Net SellingNet Selling
BGNE3.50%35.00%Net SellingNet Selling
View Top Biotech Stocks

Royalty Pharma Stock Ownership FAQ

Who owns Royalty Pharma?

Royalty Pharma (NASDAQ: RPRX) is owned by 48.10% institutional shareholders, 16.18% Royalty Pharma insiders, and 35.71% retail investors. Adage Capital Partners GP LLC is the largest individual Royalty Pharma shareholder, owning 38.71M shares representing 6.38% of the company. Adage Capital Partners GP LLC's Royalty Pharma shares are currently valued at $1.25B.

If you're new to stock investing, here's how to buy Royalty Pharma stock.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.